POST-APPROVAL SAFETY STUDY (PASS) OF THE UTILIZATION PATTERN OF APIXABAN IN SWEDEN

First published 19/11/2013

Last updated 13/03/2024

EU PAS number:

EUPAS5177

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

cv185103st-prot (pfizer-protocol-b0661017)

English (127.33 KB - PDF)View document

Updated protocol

cv185103st-prot-may2015 (pfizer-protocol-b0661017)-red

First published: 22/02/2024

English (1.53 MB - PDF)View document

Study results

Study results

study-cv185103st-csr-final-red

English (1.09 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents